549 related articles for article (PubMed ID: 27829333)
1. Immune Status 'in Children with Beta Thalassemia' in Correlation 'with Iron Overload': Single Center Egyptian Study.
Hagag AA; Elgamsy MA; El-Asy HM; Gamal RM; Elshahaby WN; Abd Elbar ES
Endocr Metab Immune Disord Drug Targets; 2016; 16(3):181-188. PubMed ID: 27829333
[TBL] [Abstract][Full Text] [Related]
2. Study of Serum Immunoglobulin Levels and T lymphocyte Subsets in Children with Beta Thalassemia with Iron Overload in Egypt.
Hagag AA; Elgamasy MA; Abd Elbar ES
Egypt J Immunol; 2016 Jan; 23(1):97-105. PubMed ID: 28502157
[TBL] [Abstract][Full Text] [Related]
3. Study of Male Sex Hormone Levels in Male Egyptian Children with Beta-Thalassemia: Correlation with Iron load.
Hagag AA; Badraia IM; Elfarargy MS; El-Enein AMA
Endocr Metab Immune Disord Drug Targets; 2016; 16(2):124-130. PubMed ID: 27215646
[TBL] [Abstract][Full Text] [Related]
4. Study of gonadal hormones in Egyptian female children with sickle cell anemia in correlation with iron overload: Single center study.
Hagag AA; El-Farargy MS; Elrefaey S; Abo El-enein AM
Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):1-7. PubMed ID: 26684919
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic value of combined therapy with deferiprone and silymarin as iron chelators in Egyptian children with beta thalassemia major.
Hagag AA; Elfaragy MS; Elrifaey SM; Abd El-Lateef AE
Infect Disord Drug Targets; 2015; 15(3):189-95. PubMed ID: 26239735
[TBL] [Abstract][Full Text] [Related]
6. Immunological evaluation of β-thalassemia major patients receiving oral iron chelator deferasirox.
Aleem A; Shakoor Z; Alsaleh K; Algahtani F; Iqbal Z; Al-Momen A
J Coll Physicians Surg Pak; 2014 Jul; 24(7):467-71. PubMed ID: 25052967
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the distribution of lymphocyte subsets and zinc levels in multitransfused beta-thalassemia major patients.
Al-Awadhi AM; Alfadhli SM; Al-Khaldi D; Borhama M; Borusly M
Int J Lab Hematol; 2010 Apr; 32(2):191-6. PubMed ID: 19453575
[TBL] [Abstract][Full Text] [Related]
8. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
[TBL] [Abstract][Full Text] [Related]
9. Gonadal Hormones in Adolescent Females with β-Thalassemia in Relation to Iron Load.
Hagag AA; Badraia IM; Elfarargy MS; Abo El-Enein AM
Endocr Metab Immune Disord Drug Targets; 2016; 16(2):148-153. PubMed ID: 27150601
[TBL] [Abstract][Full Text] [Related]
10. Major Depression in Children with Transfusion-Dependent Thalassemia Is Strongly Associated with the Combined Effects of Blood Transfusion Rate, Iron Overload, and Increased Pro-inflammatory Cytokines.
Al-Hakeim HK; Najm AH; Al-Dujaili AH; Maes M
Neurotox Res; 2020 Jun; 38(1):228-241. PubMed ID: 32335809
[TBL] [Abstract][Full Text] [Related]
11. Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity.
Gharagozloo M; Karimi M; Amirghofran Z
Ann Hematol; 2009 Jan; 88(1):21-7. PubMed ID: 18690440
[TBL] [Abstract][Full Text] [Related]
12. Thyroid Function in Egyptian Children with Sickle Cell Anemia in Correlation with Iron Load.
Hagag AA; El-Asy HM; Badraia IM; Hablas NM; El-Latif AEA
Endocr Metab Immune Disord Drug Targets; 2019; 19(1):46-52. PubMed ID: 30207251
[TBL] [Abstract][Full Text] [Related]
13. Intracellular iron overload leading to DNA damage of lymphocytes and immune dysfunction in thalassemia major patients.
Shaw J; Chakraborty A; Nag A; Chattopadyay A; Dasgupta AK; Bhattacharyya M
Eur J Haematol; 2017 Nov; 99(5):399-408. PubMed ID: 28815805
[TBL] [Abstract][Full Text] [Related]
14. Association of iron overload and oxidative stress with insulin resistance in transfusion-dependent beta-thalassemia major and beta-thalassemia/HbE patients.
Tangvarasittichai S; Pimanprom A; Choowet A; Tangvarasittichai O
Clin Lab; 2013; 59(7-8):861-8. PubMed ID: 24133917
[TBL] [Abstract][Full Text] [Related]
15. A study of innate and adaptive immune responses in beta-thalassemic patients with chronic hepatitis C virus infection.
Al-Ofairi BA; Barakat AB; Ghanim Hel-D; Shehata IH; El-Sayed MH
Egypt J Immunol; 2011; 18(1):61-76. PubMed ID: 23082481
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between growth disorders and iron overload in children with beta-thalassemia major].
Huang YL; Liu S; Xia T; Hao WG; Liang W; Sun X
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):603-6. PubMed ID: 18947480
[TBL] [Abstract][Full Text] [Related]
17. Premature atherosclerosis in children with beta-thalassemia major: New diagnostic marker.
Sherief LM; Dawood O; Ali A; Sherbiny HS; Kamal NM; Elshanshory M; Alazez OA; Alhady MA; Nour M; Mokhtar WA
BMC Pediatr; 2017 Mar; 17(1):69. PubMed ID: 28279156
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of hepatic iron overload in Chinese children with β-thalassemia major.
Xu LH; Fang JP; Xu HG; Weng WJ
Pediatr Hematol Oncol; 2011 Nov; 28(8):702-7. PubMed ID: 21970505
[TBL] [Abstract][Full Text] [Related]
19. Unbalanced bone turnover in children with beta-thalassemia.
Salama OS; Al-Tonbary YA; Shahin RA; Eldeen OA
Hematology; 2006 Jun; 11(3):197-202. PubMed ID: 17325962
[TBL] [Abstract][Full Text] [Related]
20. Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt.
El-Beshlawy A; El-Ghamrawy M; EL-Ela MA; Said F; Adolf S; Abdel-Razek AR; Magdy RI; Abdel-Salam A
Ann Hematol; 2014 Dec; 93(12):2045-50. PubMed ID: 25062719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]